跳至主要内容
临床试验/ITMCTR2200006122
ITMCTR2200006122招募中未知

RCT studies

The First Affiliated Hospital of Henan University of CM0 个研究点开始时间: 待定最近更新:
适应症

试验速览

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

性别
All

入选标准

  • (1) Age: 18 to 65 years old, regardless of gender.
  • (2) Meeting both Chinese and Western medical diagnostic criteria.
  • (3) 1 times the upper limit of normal < serum ALT decreased = 3 times the upper limit of normal for more than 4 weeks.
  • (4) Fasting blood glucose = 7.0 mmol/L.
  • (5) Signed informed consent.
  • (6) Not taking other drugs for the treatment of NAFLD or who have discontinued other drugs for the treatment of NASH before 4 weeks of inclusion for observation.

排除标准

  • (1) viral hepatitis, drug-related liver disease, total parenteral nutrition, hepatomegaly, autoimmune liver disease, etc.
  • (2) Those suffering from serious heart, brain, kidney, hematopoietic system diseases and emotional diseases such as anxiety, depression and psychiatric disorders.
  • (3) Fatty liver caused by long-term use of glucocorticoids, chlorpromazine, insulin, etc.
  • (4) Patients with type I diabetes mellitus.
  • (5) Patients with various types of malignant tumors or those with previous history of malignant tumors
  • (6) Pregnant and lactating women.
  • (7) Those who are participating in other clinical trials.

研究者

相似试验